Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring
Seguro, Fernanda Salles, Silva, Carolina Maria Pinto Domingues Carvalho, Moura, Carla Maria Boquimpani de, Conchon, Monika, Fogliatto, Laura, Funke, Vaneuza Araujo Moreira, Abdo, André, Macedo, Ariane Vieira Scarlatelli, Santos, Marilia Harumi Higushi dos, Saraiva, José Francisco Kerr
Published in Hematology, Transfusion and Cell Therapy (01.04.2021)
Published in Hematology, Transfusion and Cell Therapy (01.04.2021)
Get full text
Journal Article
Dasatinib - clinical trials and management of adverse events in imatinib resistant/intolerant chronic myeloid leukemia
Conchon, Monika, Freitas, Carla Maria Boquimpani de Moura, Rego, Maria Aparecida do Carmo, Braga Junior, José Wilson Ramos
Published in Revista brasileira de hematologia e hemoterapia (2011)
Published in Revista brasileira de hematologia e hemoterapia (2011)
Get full text
Journal Article
Importância e financiamento do monitoramento molecular (bcr-abl) no tratamento da leucemia mieloide crônica (lmc) no SUS: uma necessidade urgente para a gestão do tratamento
Carla Maria Boquimpani de Moura Freitas, André Néder Ramires Abdo, Denise Pires Martins, Luciana Britto de Abreu Lima, Mayde Seadi Torriani, Israel Bendit
Published in Jornal de Assistência Farmacêutica e Farmacoeconomia (01.02.2023)
Published in Jornal de Assistência Farmacêutica e Farmacoeconomia (01.02.2023)
Get full text
Journal Article
Impact of Mutations in Blood Cancer-Related Genes on Clinical Outcomes in Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after ≥2 Tyrosine Kinase Inhibitors (TKIs) in the Ascembl Trial
Branford, Susan, Hochhaus, Andreas, Mauro, Michael, Minami, Yosuke, Rea, Delphine, Boquimpani De Moura Freitas, Carla Maria, Serrano-Fernandez, Pablo, Obourn, Vanessa, Bruederle, Andreas, Espurz, Noemi, Hughes, Timothy P
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Sustained Efficacy and Safety with Asciminib (ASC) after Almost 4 Years of Median Follow-up from Ascembl, a Phase 3 Study of ASC Vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after ≥2 Prior Tyrosine Kinase Inhibitors (TKIs): An End of Study Treatment (EOS Tx) Update, Including Results from Switch Population
Mauro, Michael, Minami, Yosuke, Hochhaus, Andreas, Lomaia, Elza, Voloshin, Sergei, Turkina, Anna, Kim, Dong-Wook, Apperley, Jane F, Cortes, Jorge, Abdo, Andre N.R., Fogliatto, Laura Maria, Kim, Dennis Dong Hwan, le Coutre, Philipp, Saussele, Susanne, Annunziata, Mario, Hughes, Timothy P, Chaudhri, Naeem A., Chee, Lynette C.Y., García Gutiérrez, Valentín, Sasaki, Koji, Boquimpani De Moura Freitas, Carla Maria, Kapoor, Shruti, Espurz, Noemi, Dhamal, Vishal, Rea, Delphine
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Chronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012
de Souza, Carmino Antonio, Pagnano, Katia Borgia Barbosa, Bendit, Israel, Conchon, Monika, Freitas, Carla Maria Boquimpani de Moura, Coelho, Arthur Moellmann, Funke, Vaneuza Araújo Moreira, Bernardo, Wanderley Marques
Published in Revista brasileira de hematologia e hemoterapia (2012)
Published in Revista brasileira de hematologia e hemoterapia (2012)
Get full text
Journal Article